NRAS and cutaneous melanoma: Analysis of cutaneous melanoma data in The Cancer Genome Atlas has shown that the prevalence of BRAF mutations is ~45% (90% of which is V600E), followed by a prevalence of the NRAS oncogene exon 3/codon 61 of 15–20%, while other RAS mutations are less frequent (KRAS, HRAS) [7].